This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignee: Synapse B.v.. Active years: 2014.
Company Filing History:
Years Active: 2014
Title: Innovations by Peter Giesen in Thrombin Activity Measurement
Introduction
Peter Giesen is an accomplished inventor based in Maastricht, Netherlands. He has made significant contributions to the field of medical diagnostics, particularly in the measurement of thrombin activity in blood samples. With a total of 2 patents, Giesen's work has the potential to enhance the understanding and treatment of coagulation disorders.
Latest Patents
Giesen's latest patents include a method for measuring thrombin activity in whole blood. This invention involves a process where a blood sample is contacted with a fluorogenic substrate of thrombin. The method allows for the generation of thrombin in the sample, followed by measuring the fluorescence emitted from the surface of the layer. This innovative approach provides a reliable means of determining thrombin activity in a clinical setting.
Another notable patent is a diagnostic test for determining the concentration of transient proteolytic activity in composite biological media. This method enables real-time monitoring of thrombin activity in blood or plasma samples. By comparing the activity of a standard preparation with invariable thrombin activity, the exact molar amount of thrombin present can be determined. This method is particularly useful for diagnosing various coagulable states in both humans and animals.
Career Highlights
Peter Giesen is associated with Synapse B.V., where he continues to develop innovative solutions in the field of diagnostics. His work has garnered attention for its practical applications in medical science, particularly in understanding coagulation processes.
Collaborations
Giesen has collaborated with notable professionals in his field, including Hendrik Coenraad Hemker and Suzette L. Beguin. These collaborations have further enriched his research and contributed to the advancement of diagnostic methods.
Conclusion
Peter Giesen's contributions to the measurement of thrombin activity represent a significant advancement in medical diagnostics. His innovative patents and collaborations highlight his commitment to improving healthcare outcomes through scientific research.